Admescope is a contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with tailor made ADME-Tox services.
The service offering is widely spread over the whole ADME-Tox area, with top-notch expertise in in vitro & in vivo drug metabolism; including metabolite profiling & identification, drug-drug interactions and quantitative bioanalysis. The right assays are always available, whether in the discovery or lead optimisation phase. The level of data interpretation can also be customized according to customer preferences.
